Table 4.
Complication | Pathophysiology | Management | Prevention |
---|---|---|---|
Intestinal failure liver disease (IFALD) | • Multifactorial condition (sepsis, intestinal anatomy, oral nutrition/EN, PN infusion modality, nutrition deficiency or excess) | • Reduce the total lipid amount and/or decrease omega-6/omega-3 PUFA ratio | • Identify/treat sepsis |
• Soybean-lipid emulsions in excess | • Revise potential inflammatory/infectious foci | • Identify/treat sepsis | |
• Steatosis (adults) | • No evidence to recommend lipid-free regimens, as well as the use of ursodeoxycholic acid, choline, taurine, or carnitine | • Preserve small intestine length and colon in continuity | |
• Hepatocellular injury or cholestasis (children) | • Increase oral/enteral intake | ||
• Cycled PN with soybean oil-based lipid content less than 1 g/kg/day | |||
Gallbladder sludge and stones | • Negligible oral intake | • Endoscopic/surgical procedures as for the general population | • Preserve small intestine length and colon in continuity |
• Intestinal remnant length less than 180 cm | • Increase oral/enteral intake | • Increase oral/enteral intake | |
• Crohn’s disease | |||
Kidney disease and stones | • Chronic dehydration (kidney disease) | • Management as for the general population | • Monitor fluid balance and renal function* |
• Increased absorption of oxalate, hypovolemia, hypomagnesemia and metabolic acidosis (kidney stones) | • Low-fat and low-oxalate diet* | ||
• Calcium carbonate and potassium citrate supplementation* | |||
Bone disease | • Toxicity from aluminum contamination of the nutrition formula | • Supplement calcium and vitamin D as needed | • Correct metabolic acidosis when present |
• Increased sensitivity to vitamin D suppressing PTH secretion | • Periodic assessment of bone mineral density, calcium, magnesium, vitamin D and supplement as needed | ||
• Hypercalciuria | |||
• Micronutrient deficiency (vitamin C and copper) | |||
• Vitamin A toxicity |
EN, enteral nutrition; PN, parenteral nutrition; PUFA, poly-unsaturated fatty acid.
*Especially in patients with colon in continuity.